Related references
Note: Only part of the references are listed.Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients
Fumihiko Sakai et al.
HEADACHE (2021)
Efficacy and safety of fremanezumab for chronic migraine prevention: Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients
Fumihiko Sakai et al.
HEADACHE (2021)
Long-term safety, tolerability, and efficacy of fremanezumab in migraine A randomized study
Peter J. Goadsby et al.
NEUROLOGY (2020)
Long-term treatment patterns of prophylactic and acute migraine medications and incidence of opioid-related adverse events in patients with migraine
Machaon Bonafede et al.
CEPHALALGIA (2019)
Real-world treatment patterns and patient-reported outcomes in episodic and chronic migraine in Japan: analysis of data from the Adelphi migraine disease specific programme
Kaname Ueda et al.
JOURNAL OF HEADACHE AND PAIN (2019)
CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications
David W. Dodick
CEPHALALGIA (2019)
Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine A Randomized Clinical Trial
David W. Dodick et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
CGRP as the target of new migraine therapies - successful translation from bench to clinic
Lars Edvinsson et al.
NATURE REVIEWS NEUROLOGY (2018)
Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis
Zsolt Hepp et al.
CEPHALALGIA (2017)
Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the United States
J. Michael Woolley et al.
HEADACHE (2017)
Fremanezumab for the Preventive Treatment of Chronic Migraine
Stephen D. Silberstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Adherence to oral migraine-preventive medications among patients with chronic migraine
Zsolt Hepp et al.
CEPHALALGIA (2015)
Systematic Review of Migraine Prophylaxis Adherence and Persistence
Zsolt Hepp et al.
JOURNAL OF MANAGED CARE PHARMACY (2014)
Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study (IBMS-II)
Andrew M. Blumenfeld et al.
HEADACHE (2013)
Tolerance and Loss of Beneficial Effect During Migraine Prophylaxis: Clinical Considerations
Elizabeth W. Loder et al.
HEADACHE (2011)
Feasibility and validation of a computer-automated Columbia-Suicide severity rating scale using interactive voice response technology
James C. Mundt et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2010)
A six-item short-form survey for measuring headache impact: The HIT-6 (TM)
M Kosinski et al.
QUALITY OF LIFE RESEARCH (2003)
Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability
WF Stewart et al.
NEUROLOGY (2001)
Share Paper
